|
Through two new initiatives, the U.S. Food and Drug Administration (FDA) is working to ensure pulse oximetry is equitable and accurate for all patients.
- On February 2, 2024, the FDA will host a virtual public advisory committee meeting.
- Today, the FDA published a new discussion paper to obtain public comment.
The FDA encourages your participation in both initiatives.
|
Get Involved
Questions?
If you have questions about this announcement, contact the Division of Industry and Consumer Education.
|
|
|
|